Bio-Rad Laboratories (BIO) Non-Current Debt (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Non-Current Debt for 18 consecutive years, with $1.2 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non-Current Debt changed 0.22% year-over-year to $1.2 billion in Q2 2026; TTM through Jun 2026 was $1.2 billion, a 0.22% change from a year earlier, with the FY2025 full-year figure at $1.2 billion, changed 0.22% from the prior year.
• Non-Current Debt was $1.2 billion for Q2 2026 at Bio-Rad Laboratories, roughly flat from $1.2 billion in the prior quarter.
• Over five years, Non-Current Debt peaked at $1.2 billion in Q2 2026 and troughed at $1.2 billion in Q1 2022.
• A 5-year average of $1.2 billion and a median of $1.2 billion in 2024 frame the typical range for Non-Current Debt.
• Across the five-year window, Non-Current Debt soared 11291.63% in 2022 and rose 0.11% in 2023, its largest moves.
• Over 5 years, Non-Current Debt stood at $1.2 billion in 2022, then increased by 0.12% to $1.2 billion in 2023, then advanced by 0.11% to $1.2 billion in 2024, then grew by 0.22% to $1.2 billion in 2025, then gained by 0.06% to $1.2 billion in 2026.
• The last three Non-Current Debt figures came in at $1.2 billion (Q2 2026), $1.2 billion (Q1 2026), and $1.2 billion (Q4 2025), per Business Quant data.